Published in Nature on August 24, 1978
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J Virol (1985) 4.76
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol (1987) 3.58
Methylation of Herpesvirus saimiri DNA in lymphoid tumor cell lines. Proc Natl Acad Sci U S A (1979) 3.24
Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J Virol (1982) 3.16
A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J Virol (1988) 2.27
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05
A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes. J Virol (1988) 1.99
p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J (1991) 1.91
Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A (1979) 1.90
Polypeptides of the Epstein-Barr virus membrane antigen complex. J Virol (1979) 1.86
Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One (2008) 1.70
Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med (1986) 1.60
Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey. Proc Natl Acad Sci U S A (1982) 1.39
Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer (2008) 1.35
Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis (2012) 1.35
Genital herpes: hype or hope? Br Med J (Clin Res Ed) (1983) 1.25
Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines. Proc Natl Acad Sci U S A (1986) 1.22
Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340. EMBO J (1985) 1.19
Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer (2009) 1.16
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol (2009) 1.16
Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol (2009) 1.15
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet (2013) 1.15
Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells. J Virol (1987) 1.13
Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment. J Virol (1990) 1.09
Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J Clin Invest (1999) 1.05
Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol (2003) 1.03
Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. J Clin Microbiol (2006) 1.03
The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): past medical history in children with cancer. J Epidemiol Community Health (1988) 1.02
Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study. Infect Agent Cancer (2010) 1.01
A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. Br J Cancer (2006) 1.00
Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs. J Virol (1996) 0.99
The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis (2011) 0.98
African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg (2011) 0.97
Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: a case control study. Infect Agent Cancer (2006) 0.96
Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins. Mol Cell Biol (2002) 0.96
Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. PLoS One (2008) 0.96
Are plant factors a missing link in the evolution of endemic Burkitt's lymphoma? Br J Cancer (1993) 0.94
Cellular and Epstein-Barr virus specific DNA polymerases in virus-producing Burkitt's lymphoma cell lines. Nucleic Acids Res (1982) 0.93
T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Proc Natl Acad Sci U S A (2003) 0.92
No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients. Proc Natl Acad Sci U S A (1984) 0.92
Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. J Virol (1994) 0.92
Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr Blood Cancer (2012) 0.92
Burkitt Lymphoma: beyond discoveries. Infect Agent Cancer (2013) 0.91
Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature. Am J Epidemiol (2014) 0.90
Tissue distribution of Epstein-Barr virus genotypes. J Virol (1996) 0.89
Herpesviruses. J Clin Pathol (1979) 0.89
Hypothesis: the pathogenesis of AIDS. Activation of the T- and B-cell cascades. Yale J Biol Med (1984) 0.88
Epstein-barr virus vaccines. Clin Transl Immunology (2015) 0.88
The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J Virol (2001) 0.88
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine. Clin Exp Immunol (1983) 0.88
Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer (2016) 0.88
Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women. J Infect Dis (2013) 0.87
Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue. J Clin Pathol (1990) 0.87
Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation. J Virol (2012) 0.86
Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. PLoS One (2010) 0.86
Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells. J Virol (2007) 0.86
Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer (2003) 0.85
Serodiagnosis for tumor viruses. Semin Oncol (2014) 0.85
Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load. J Infect Dis (2013) 0.83
Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study. BMC Infect Dis (2003) 0.83
Autoantibodies in three populations of Burkitt's lymphoma patients. Clin Exp Immunol (1983) 0.83
Orbital sporadic Burkitt lymphoma in an adult diabetic African American female and a review of adult orbital cases. Clin Ophthalmol (2011) 0.82
Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence. PLoS One (2014) 0.82
Abdominal Burkitt-type lymphomas in Algeria. Br J Cancer (1984) 0.82
A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect Agent Cancer (2012) 0.82
Age of infection and risk of virally associated cancers: new clues to an old puzzle. J Infect Dis (2012) 0.81
A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to children. Trop Med Int Health (2010) 0.81
Epstein-Barr virus-lymphoid cell interactions. III. Effect of concanavalin A and saccharides on Epstein-Barr virus penetration. J Virol (1982) 0.80
Viruses and human cancers: challenges for preventive strategies. Environ Health Perspect (1995) 0.80
Evidence of an oncogenic gammaherpesvirus in domestic dogs. Virology (2012) 0.80
A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal. Adv Hematol (2011) 0.80
Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA. Proc Natl Acad Sci U S A (2013) 0.80
Historical review of the causes of cancer. World J Clin Oncol (2016) 0.79
Overview: viral agents and cancer. Environ Health Perspect (1995) 0.79
Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase. Biochem J (2004) 0.79
Genome-wide genetic investigation of serological measures of common infections. Eur J Hum Genet (2015) 0.79
Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients. J Clin Immunol (2012) 0.79
Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy. Clin Vaccine Immunol (2015) 0.79
Clinical features of Epstein-Barr virus-associated infectious mononucleosis in hospitalized Korean children. Korean J Pediatr (2011) 0.78
Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas. Virol J (2012) 0.78
The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers. Br J Cancer (1986) 0.78
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Front Microbiol (2014) 0.78
Epstein-Barr virus: the path from association to causality for a ubiquitous human pathogen. PLoS Biol (2014) 0.78
Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations. Sci Rep (2015) 0.78
Nuclear translocation and regulation of intranuclear distribution of cytoplasmic poly(A)-binding protein are distinct processes mediated by two Epstein Barr virus proteins. PLoS One (2014) 0.77
Functional cross-reactivity between the glycoprotein B of herpes simplex virus type 1 and Epstein-Barr virus. Immunology (1989) 0.77
Infectious Mononucleosis. Curr Top Microbiol Immunol (2015) 0.77
The clinical illness promotion factor: a third ingredient. Yale J Biol Med (1983) 0.76
The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based survey. Infect Agent Cancer (2014) 0.76
Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus. MBio (2016) 0.76
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. Adv Hematol (2012) 0.75
Selective activation of TCR-gammadelta+ cells in endemic Burkitt's lymphoma. Malar J (2007) 0.75
Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line. Br J Cancer (1986) 0.75
Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature. Exp Hematol Oncol (2016) 0.75
Value of a multinational approach in determining the causation of cancer. Yale J Biol Med (1987) 0.75
Obituary for guy de thé. Retrovirology (2015) 0.75
Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection. J Infect Dis (2016) 0.75
Induced hydrolytic activity of yeast phenylalanyl-tRNA synthetase by tRNAPhe-CC. Nucleic Acids Res (1982) 0.75
Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis. Ecancermedicalscience (2014) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu. J Infect Dis (1972) 24.30
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol (1966) 18.33
Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ (1980) 15.47
DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science (1988) 13.46
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
INTERFERENCE OF INACTIVE VIRUS WITH THE PROPAGATION OF VIRUS OF INFLUENZA. Science (1943) 10.31
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet (1984) 10.22
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A (1968) 8.67
Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science (1967) 8.62
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science (1970) 7.60
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science (1985) 6.31
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet (1984) 5.87
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Disease susceptibility genes--their identification by multiple case family studies. Tissue Antigens (1976) 5.17
Mortality of workers at the Sellafield plant of British Nuclear Fuels. Br Med J (Clin Res Ed) (1986) 4.94
Impact of permethrin impregnated bednets on child mortality in Kassena-Nankana district, Ghana: a randomized controlled trial. Trop Med Int Health (1996) 4.88
Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol (1978) 4.76
Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics (1984) 4.73
Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer (1997) 4.47
Monitoring the prevalence of HIV. BMJ (1989) 4.46
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : I. THE DISPERSION OF THE VIRUS OF INFLUENZA A IN TISSUE EMULSIONS AND IN EXTRA-EMBRYONIC FLUIDS OF THE CHICK. J Exp Med (1943) 4.30
Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA (1968) 4.26
Carboxyhaemoglobin levels in smokers of filter and plain cigarettes. Lancet (1977) 4.22
Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst (1966) 4.19
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol (1983) 4.11
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11
Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis (2000) 4.06
Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet (1987) 4.01
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Breast cancer treatment and natural history: new insights from results of screening. Lancet (1992) 3.77
Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer (1987) 3.69
NEUROLOGICAL SIGNS IN MICE FOLLOWING INTRACEREBRAL INOCULATION OF INFLUENZA VIRUSES. Science (1944) 3.61
Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol (1974) 3.58
Multistage models and primary prevention of cancer. J Natl Cancer Inst (1980) 3.55
Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst (2004) 3.53
Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet (1999) 3.39
Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer (1976) 3.36
High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci U S A (1985) 3.35
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (2001) 3.35
Epidemic misuse. Nature (1993) 3.34
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
THE EFFECT OF VITAMIN B(1) DEFICIENCY AND OF RESTRICTED FOOD INTAKE ON THE RESPONSE OF MICE TO THE LANSING STRAIN OF POLIOMYELITIS VIRUS. J Exp Med (1944) 3.17
SEROLOGICAL SPECIFICITY OF HEAVY PARTICLES DERIVED FROM NORMAL ORGANS. Science (1940) 3.12
Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol (1968) 3.09
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst (1969) 3.07
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis (1975) 3.02
Characteristics of human herpesvirus-6. J Infect Dis (1988) 3.02
Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med (1968) 3.01
Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int J Cancer (1971) 3.00
An outbreak of foodborne giardiasis. N Engl J Med (1981) 2.98
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96
Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol (1984) 2.96
Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer (1973) 2.93
The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol (2003) 2.89
Isopods associated with fishes: a synopsis and corrections. J Parasitol (1998) 2.87
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83
Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS (1990) 2.83
Environmental stress sensitivity of an ascorbic acid-deficient Arabidopsis mutant. Proc Natl Acad Sci U S A (1996) 2.79
Genetic evidence for the role of GDP-mannose in plant ascorbic acid (vitamin C) biosynthesis. Proc Natl Acad Sci U S A (1999) 2.71
Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr (2003) 2.68
Scheduling of revaccination against hepatitis B virus. Lancet (1991) 2.65
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Indirect standardization and multiplicative models for rates, with reference to the age adjustment of cancer incidence and relative frequency data. J Chronic Dis (1975) 2.62
Association between atherosclerotic diseases and carboxyhaemoglobin levels in tobacco smokers. Br Med J (1973) 2.62
AIDS predictions. Lancet (1993) 2.56
STUDIES ON THE COMPLEMENT FIXATION ANTIGENS OF INFLUENZA VIRUSES TYPES A AND B. J Exp Med (1946) 2.50
Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) (1982) 2.46
Burkitt's tumour in the West Nile District Uganda, 1961-5. Br Med J (1967) 2.43
Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells. J Bacteriol (1966) 2.42
Methyldopa liver damage. Br Med J (1974) 2.40
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer (1999) 2.36
The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol (1984) 2.35
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc Natl Acad Sci U S A (1986) 2.34
A multipurpose serological survey in Kenya. 2. Results of arbovirus serological tests. Bull World Health Organ (1970) 2.34
Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes. Science (1985) 2.28
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
Leukemia following Hodgkin's disease. N Engl J Med (1990) 2.25
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer (2003) 2.24
STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : II. THE SIZE OF THE INFECTIOUS UNIT IN INFLUENZA A. J Exp Med (1943) 2.24
Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr (2001) 2.21
Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med (1995) 2.20
Enterotoxin-producing Escherichia coli and diarrheal disease in adult travelers: a prospective study. J Infect Dis (1974) 2.19